These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10487105)

  • 1. [Costs of different intervention strategies to prevent hip fractures].
    Vestergaard P; Mosekilde L
    Ugeskr Laeger; 1999 Aug; 161(31):4400-5. PubMed ID: 10487105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents.
    Singh S; Sun H; Anis AH
    J Rheumatol; 2004 Aug; 31(8):1607-13. PubMed ID: 15290742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
    Buckley LM; Hillner BE
    J Rheumatol; 2003 Jan; 30(1):132-8. PubMed ID: 12508402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Economic expenditures of different intervention regimes in the prevention of hip fractures].
    Diemer H
    Ugeskr Laeger; 1999 Sep; 161(38):5327-8. PubMed ID: 10536521
    [No Abstract]   [Full Text] [Related]  

  • 6. Supplemental calcium for the prevention of hip fracture: potential health-economic benefits.
    Bendich A; Leader S; Muhuri P
    Clin Ther; 1999 Jun; 21(6):1058-72. PubMed ID: 10440627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The necessity of cost-effectiveness analysis in osteoporosis].
    Lamy O; Krieg MA
    Rev Med Suisse; 2007 Jun; 3(115):1521-5. PubMed ID: 17682796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-benefit analysis of external hip protectors in the nursing home setting.
    Honkanen LA; Schackman BR; Mushlin AI; Lachs MS
    J Am Geriatr Soc; 2005 Feb; 53(2):190-7. PubMed ID: 15673340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [External hip protectors against hip fractures. A randomized study in a nursing home].
    Lauritzen JB; Petersen MM; Lund B
    Ugeskr Laeger; 1993 May; 155(20):1523-6. PubMed ID: 8316982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postmenopausal osteoporosis].
    László A
    Orv Hetil; 2004 Jan; 145(1):3-13. PubMed ID: 15222134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in external hip protectors].
    Koike T
    Clin Calcium; 2006 Sep; 16(9):1493-99. PubMed ID: 16951474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of osteoporosis].
    Dambacher MA; Kissling R; Neff M
    Ther Umsch; 1998 Nov; 55(11):702-11. PubMed ID: 9865147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-utility and budget impact analysis of primary prevention with alendronate of osteoporotic hip fractures in Catalonia.
    Pueyo MJ; Larrosa M; Surís X; Garcia-Ruiz AJ
    Reumatol Clin; 2012; 8(3):128-34. PubMed ID: 22421456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmaco-economic evaluation of drug therapy osteoporosis. A literature review].
    Christensen PM; Brøsen K; Brixen KT; Beck-Nielsen H; Søgaard J; Kristiansen IS
    Ugeskr Laeger; 2002 Mar; 164(10):1339-45. PubMed ID: 11894425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fracture prevention in postmenopausal women.
    Bruyere O; Edwards J; Reginster JY
    Clin Evid; 2003 Jun; (9):1186-202. PubMed ID: 12967416
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of hip fractures: medical and nonmedical management.
    Lin JT; Lane JM
    Instr Course Lect; 2004; 53():417-25. PubMed ID: 15116631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.
    Andrade SE; Majumdar SR; Chan KA; Buist DS; Go AS; Goodman M; Smith DH; Platt R; Gurwitz JH
    Arch Intern Med; 2003 Sep; 163(17):2052-7. PubMed ID: 14504118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis management.
    Rozenberg S; Vandromme J; Ayata NB; Filippidis M; Kroll M
    Int J Fertil Womens Med; 1999; 44(5):241-9. PubMed ID: 10569453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.